Novel Mutation in the CASR Gene (p.Leu123Ser) in a Case of Autosomal Dominant Hypocalcemia

Joana Regala, Branca Cavaco, Ana Rita Domingues, Catarina Limbert, Lurdes Lopes

Research output: Contribution to journalArticle

Abstract

Autosomal dominant hypocalcemia, caused by activating mutations of the calcium-sensing receptor (CASR) gene, is characterized by hypocalcemia with an inappropriately low concentration of parathyroid hormone (PTH). In this report, we describe the identification of a novel missense mutation in the CASR gene, in a boy with autosomal dominant hypocalcemia. Polymerase chain reaction (PCR)-single strand and DNA sequencing revealed a heterozygous mutation in CASR gene that causes a leucine substitution for serine at codon 123 (p.Leu123Ser). This mutation was absent in DNA from 50 control patients. In silico studies suggest that the identified variant was likely pathogenic. Sequencing analysis in the mother suggested mosaicism for the same variant, and she was clinically and biochemically unaffected. Clinical manifestations of the index case started with seizures at 14 months of age; cognitive impairment and several neuropsychological disabilities were noted during childhood. Extrapyramidal signs and basal ganglia calcification developed later, namely, hand tremor and rigidity at the age of 7 and 18 years, respectively. Laboratory analysis revealed hypocalcemia, hyperphosphatemia, and low-serum PTH with hypomagnesemia and mild hypercalciuria. After 2 years of treatment with calcium supplements and calcitriol, some brief periods of clinical improvement were reported; as well as an absence of nephrocalcinosis.

Original languageEnglish
Pages (from-to)29-33
Number of pages5
JournalJournal of pediatric genetics
Volume4
Issue number1
DOIs
Publication statusPublished - Mar 2015

Fingerprint

Calcium-Sensing Receptors
Hypocalcemia
Parathyroid Hormone
Mutation
Nephrocalcinosis
Genes
Hyperphosphatemia
Hypercalciuria
Mosaicism
Calcitriol
Tremor
Missense Mutation
Basal Ganglia
DNA Sequence Analysis
Codon
Leucine
Computer Simulation
Serine
Seizures
Hand

Keywords

  • autosomal dominant hypocalcemia
  • calcium-sensing receptor
  • missense mutation
  • mosaicism

Cite this

Regala, Joana ; Cavaco, Branca ; Domingues, Ana Rita ; Limbert, Catarina ; Lopes, Lurdes. / Novel Mutation in the CASR Gene (p.Leu123Ser) in a Case of Autosomal Dominant Hypocalcemia. In: Journal of pediatric genetics. 2015 ; Vol. 4, No. 1. pp. 29-33.
@article{c085835b24fd4828b95169e9e61e0e41,
title = "Novel Mutation in the CASR Gene (p.Leu123Ser) in a Case of Autosomal Dominant Hypocalcemia",
abstract = "Autosomal dominant hypocalcemia, caused by activating mutations of the calcium-sensing receptor (CASR) gene, is characterized by hypocalcemia with an inappropriately low concentration of parathyroid hormone (PTH). In this report, we describe the identification of a novel missense mutation in the CASR gene, in a boy with autosomal dominant hypocalcemia. Polymerase chain reaction (PCR)-single strand and DNA sequencing revealed a heterozygous mutation in CASR gene that causes a leucine substitution for serine at codon 123 (p.Leu123Ser). This mutation was absent in DNA from 50 control patients. In silico studies suggest that the identified variant was likely pathogenic. Sequencing analysis in the mother suggested mosaicism for the same variant, and she was clinically and biochemically unaffected. Clinical manifestations of the index case started with seizures at 14 months of age; cognitive impairment and several neuropsychological disabilities were noted during childhood. Extrapyramidal signs and basal ganglia calcification developed later, namely, hand tremor and rigidity at the age of 7 and 18 years, respectively. Laboratory analysis revealed hypocalcemia, hyperphosphatemia, and low-serum PTH with hypomagnesemia and mild hypercalciuria. After 2 years of treatment with calcium supplements and calcitriol, some brief periods of clinical improvement were reported; as well as an absence of nephrocalcinosis.",
keywords = "autosomal dominant hypocalcemia, calcium-sensing receptor, missense mutation, mosaicism",
author = "Joana Regala and Branca Cavaco and Domingues, {Ana Rita} and Catarina Limbert and Lurdes Lopes",
year = "2015",
month = "3",
doi = "10.1055/s-0035-1554979",
language = "English",
volume = "4",
pages = "29--33",
journal = "Journal of pediatric genetics",
issn = "2146-460X",
publisher = "IOS Press",
number = "1",

}

Novel Mutation in the CASR Gene (p.Leu123Ser) in a Case of Autosomal Dominant Hypocalcemia. / Regala, Joana; Cavaco, Branca; Domingues, Ana Rita; Limbert, Catarina; Lopes, Lurdes.

In: Journal of pediatric genetics, Vol. 4, No. 1, 03.2015, p. 29-33.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel Mutation in the CASR Gene (p.Leu123Ser) in a Case of Autosomal Dominant Hypocalcemia

AU - Regala, Joana

AU - Cavaco, Branca

AU - Domingues, Ana Rita

AU - Limbert, Catarina

AU - Lopes, Lurdes

PY - 2015/3

Y1 - 2015/3

N2 - Autosomal dominant hypocalcemia, caused by activating mutations of the calcium-sensing receptor (CASR) gene, is characterized by hypocalcemia with an inappropriately low concentration of parathyroid hormone (PTH). In this report, we describe the identification of a novel missense mutation in the CASR gene, in a boy with autosomal dominant hypocalcemia. Polymerase chain reaction (PCR)-single strand and DNA sequencing revealed a heterozygous mutation in CASR gene that causes a leucine substitution for serine at codon 123 (p.Leu123Ser). This mutation was absent in DNA from 50 control patients. In silico studies suggest that the identified variant was likely pathogenic. Sequencing analysis in the mother suggested mosaicism for the same variant, and she was clinically and biochemically unaffected. Clinical manifestations of the index case started with seizures at 14 months of age; cognitive impairment and several neuropsychological disabilities were noted during childhood. Extrapyramidal signs and basal ganglia calcification developed later, namely, hand tremor and rigidity at the age of 7 and 18 years, respectively. Laboratory analysis revealed hypocalcemia, hyperphosphatemia, and low-serum PTH with hypomagnesemia and mild hypercalciuria. After 2 years of treatment with calcium supplements and calcitriol, some brief periods of clinical improvement were reported; as well as an absence of nephrocalcinosis.

AB - Autosomal dominant hypocalcemia, caused by activating mutations of the calcium-sensing receptor (CASR) gene, is characterized by hypocalcemia with an inappropriately low concentration of parathyroid hormone (PTH). In this report, we describe the identification of a novel missense mutation in the CASR gene, in a boy with autosomal dominant hypocalcemia. Polymerase chain reaction (PCR)-single strand and DNA sequencing revealed a heterozygous mutation in CASR gene that causes a leucine substitution for serine at codon 123 (p.Leu123Ser). This mutation was absent in DNA from 50 control patients. In silico studies suggest that the identified variant was likely pathogenic. Sequencing analysis in the mother suggested mosaicism for the same variant, and she was clinically and biochemically unaffected. Clinical manifestations of the index case started with seizures at 14 months of age; cognitive impairment and several neuropsychological disabilities were noted during childhood. Extrapyramidal signs and basal ganglia calcification developed later, namely, hand tremor and rigidity at the age of 7 and 18 years, respectively. Laboratory analysis revealed hypocalcemia, hyperphosphatemia, and low-serum PTH with hypomagnesemia and mild hypercalciuria. After 2 years of treatment with calcium supplements and calcitriol, some brief periods of clinical improvement were reported; as well as an absence of nephrocalcinosis.

KW - autosomal dominant hypocalcemia

KW - calcium-sensing receptor

KW - missense mutation

KW - mosaicism

U2 - 10.1055/s-0035-1554979

DO - 10.1055/s-0035-1554979

M3 - Article

VL - 4

SP - 29

EP - 33

JO - Journal of pediatric genetics

JF - Journal of pediatric genetics

SN - 2146-460X

IS - 1

ER -